The global chronic obstructive pulmonary disease devices market size was significantly robust in 2022, and is expected to register a rapid revenue CAGR during the forecast period. Increasing need for efficient medical devices in healthcare facilities, and rising prevalence of COPD and Asthma are factors expected to drive market revenue growth over the forecast period.
The global healthcare industry has developed effective modern technologies to diagnose and treat diseases accurately, while at the same time, maintaining exceptional patient care standards. Chronic obstructive pulmonary disease (COPD) can be defined as a respiratory disorder characterized by the inflammation in lungs that produces symptoms similar to that of asthma. It is usually caused by excessive exposure to tobacco smoke and chemicals, but can also be inherited at times. Increasing prevalence of chronic respiratory diseases in geriatric population is generating growth opportunities for the market.
Request a Sample@ https://www.qyresearchmedical.com/sample/119351
The COVID-19 pandemic has significantly impacted production and manufacturing industries, which has affected the chronic obstructive pulmonary disease devices market as well. There has been sudden reduction in medical supplies, coupled with disruption of supply chains, due to extended lockdowns imposed in various countries across the world. However, with relaxations in quarantine regulations, increasing use of albuterol inhalers in coronavirus patients, and rising need for COPD devices among the younger generation, the market is expected to recover and provide significant growth opportunities for major players .
Global Chronic Obstructive Pulmonary Disease Devices Market: Dynamics
Increase in the number of people diagnosed with asthma and emphysema, rising awareness among people regarding treatment of these conditions, and extensive demand for short-term modern solutions for COPD are driving market revenue growth. More than 251 million cases of COPD were recorded across the world in 2016 by the World Health Organization (WHO). Rising prevalence of COPD is expected to increase demand for COPD devices and thus, drive revenue growth of the global market. Chronic obstructive pulmonary disease causes blockage of the airways, leading to reduced breathing activity. Development of new drug-delivery protocols is enabling personal management of medication and reduction in the need for respiratory disorder therapies. Moreover, COPD devices, including inhalers, have proved to be the most efficient treatment option, due to reliable treatment provided by them, and their high rate of adoption and portability.
Government initiatives to increase awareness about advanced inhalation devices for COPD have significantly impacted product sales and consumption. Daily exposure to pollution, rapid industrialization, increasing global population, coupled with increasing number of active smokers, are driving market revenue growth. Furthermore, introduction of smart inhalers with visible short-term treatment is improving patient engagement and providing lucrative growth opportunities. However, increase in competition in the market, high costs associated with some treatment methods, uncertain reimbursement support, and low material quality can act as major restraints to revenue growth of the global market.
Global Chronic Obstructive Pulmonary Disease Devices Market: Regional Landscape
North America accounted for largest revenue share in the global market in 2021, and is expected to maintain its leading position during the forecast period, owing to widespread adoption of inhalers and nebulizers by patients, presence of advanced healthcare facilities and well-established healthcare infrastructure, and a large patient pool of respiratory diseases. Asia-Pacific is expected to register the fastest revenue growth rate, due to rise in healthcare expenditure, increase in awareness about advanced portable COPD and asthma devices, and increasing disposable income in the region.
Major Players in the Global Chronic Obstructive Pulmonary Disease Devices Market
- Aerogen, Inc.
- AstraZeneca PLC
- Baxter International Inc.
- Boehringer Ingelheim International GmbH
- 3M Company
- GF Health Products
- GlaxoSmithKline Plc
- Koninklijke Philips N.V.
- Novartis AG
- PARI medical Holding GmbH
- Smith’s Group PLC
Report Highlights
- Regional demand and forecast estimation, along with analysis of critical factors expected to influence growth of the industry
- Pricing analysis, manufacturing cost analysis, revenue generation, gross margins, and profit margins are covered in the report
- Analysis of upstream raw materials and downstream buyers
- Competitive landscape benchmarking along with regional mapping
- R&D analysis along with product and technological developments
- Analysis of market drivers, restraints, challenges, and risks with their impact on revenue generation
- Assessment of critical parameters that are likely to influence the global market
Global Chronic Obstructive Pulmonary Disease Devices Market: Segmentation
This report contains forecasts for the market in terms of revenue at the global, regional, and country levels. The report includes analysis of trends in each segment of the market from 2023 to 2032. For this study, has segmented the global chronic obstructive pulmonary disease devices market based on product type, indication, distribution channel, and region.
Product Type Outlook (Revenue, USD Billion; 2023 – 2032)
- Inhalers
- Drug Powder Inhalers (DPIs)
- Metered Dose Inhalers (MDIs)
- Soft Mist Inhalers (SMIs)
- Nebulizers
- Compressor Nebulizers
- Ultrasonic Nebulizers
- Mesh Nebulizers
Indication Outlook (Revenue, USD Billion; 2023 – 2032)
- Asthma
- COPD
Distribution Channel Outlook (Revenue, USD Billion; 2023 – 2032)
- Retail Pharmacies
- Hospitals
- Online Pharmacies
Regional Outlook (Revenue, USD Billion; 2023 – 2032)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Benelux
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East and Africa
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East & Africa
Buy quantitative research Report at discounted price – USD 1500 https://www.qyresearchmedical.com/report/checkout/119351/1500
You can place an order or ask any questions, please feel free to contact [email protected] | +1 9197 992 333
Blog: https://www.novaoneadvisor.com/
Blog: https://www.visionresearchreports.com/
About Us
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us:
URL – http://www.qyresearchmedical.com/
https://www.linkedin.com/company/qyresearch-medical/
https://www.facebook.com/QYResearch-Medical-108186514228917/